Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | 1 | — | 2 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney transplantation | D016030 | — | — | — | — | 1 | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | — | 1 | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | — | 1 | — | — | 1 |
Drug common name | Quilizumab |
INN | quilizumab |
Description | Quilizumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109456 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 26F96HRJ3W (ChemIDplus, GSRS) |